Humalog



Indications and Reactions:

Role Indications Reactions
Primary
Diabetes Mellitus 58.7%
Type 2 Diabetes Mellitus 13.6%
Type 1 Diabetes Mellitus 12.9%
Hypertension 4.2%
Diabetes Mellitus Insulin-dependent 2.3%
Diabetes Mellitus Non-insulin-dependent 1.6%
Prophylaxis 1.1%
Gestational Diabetes 0.8%
Cardiac Disorder 0.7%
Depression 0.5%
Blood Glucose Increased 0.5%
Blood Pressure 0.5%
Pain 0.4%
Asthma 0.3%
Blood Cholesterol 0.3%
Hypothyroidism 0.3%
Blood Cholesterol Increased 0.3%
Convulsion 0.3%
Gastrooesophageal Reflux Disease 0.3%
Neuropathy Peripheral 0.3%
Visual Acuity Reduced 12.0%
Blood Glucose Increased 8.4%
Hospitalisation 6.5%
Visual Impairment 5.8%
Hypoglycaemia 5.3%
Drug Ineffective 5.2%
Wrong Drug Administered 5.1%
Loss Of Consciousness 4.9%
Weight Increased 4.7%
Wrong Technique In Drug Usage Process 4.4%
Blindness 4.4%
Weight Decreased 4.3%
Death 4.3%
Vomiting 4.2%
Pharmaceutical Product Complaint 4.0%
Renal Failure 3.8%
Incorrect Dose Administered 3.5%
Myocardial Infarction 3.5%
Hyperglycaemia 3.3%
Drug Exposure During Pregnancy 2.4%
Secondary
Type 2 Diabetes Mellitus 66.8%
Diabetes Mellitus 15.6%
Product Used For Unknown Indication 6.4%
Type 1 Diabetes Mellitus 3.8%
Hypertension 1.8%
Drug Use For Unknown Indication 1.4%
Diabetes Mellitus Insulin-dependent 0.7%
Prophylaxis 0.5%
Gestational Diabetes 0.4%
Osteoporosis 0.4%
Diabetes Mellitus Non-insulin-dependent 0.4%
Diabetic Neuropathy 0.3%
Suicide Attempt 0.3%
Depression 0.2%
Constipation 0.2%
Neuropathy Peripheral 0.2%
Pain 0.2%
Cardiac Disorder 0.2%
Hyperlipidaemia 0.1%
Gastritis 0.1%
Hypoglycaemia 11.2%
Visual Acuity Reduced 10.7%
Blood Glucose Increased 7.8%
Wrong Drug Administered 7.7%
Renal Failure Acute 6.1%
Weight Decreased 5.2%
Drug Ineffective 5.0%
Hypoglycaemic Unconsciousness 4.9%
Incorrect Dose Administered 4.6%
Visual Impairment 4.5%
Loss Of Consciousness 4.4%
Weight Increased 4.1%
Wrong Technique In Drug Usage Process 4.1%
Vomiting 3.7%
Myocardial Infarction 3.5%
Vision Blurred 2.8%
Renal Failure 2.7%
Blindness 2.6%
Pain 2.4%
Hyperglycaemia 2.2%
Concomitant
Product Used For Unknown Indication 30.7%
Drug Use For Unknown Indication 14.7%
Diabetes Mellitus 14.3%
Type 2 Diabetes Mellitus 8.6%
Hypertension 7.9%
Pain 3.7%
Type 1 Diabetes Mellitus 2.9%
Diabetes Mellitus Non-insulin-dependent 2.6%
Depression 2.0%
Rheumatoid Arthritis 1.8%
Prophylaxis 1.7%
Blood Cholesterol Increased 1.5%
Gastrooesophageal Reflux Disease 1.0%
Multiple Myeloma 1.0%
Cardiac Disorder 1.0%
Nausea 0.9%
Blood Pressure 0.9%
Asthma 0.9%
Anxiety 0.9%
Diabetes Mellitus Insulin-dependent 0.9%
Weight Decreased 19.7%
Vomiting 11.2%
Blood Glucose Increased 9.4%
Nausea 8.3%
Weight Increased 6.9%
Hypoglycaemia 4.1%
Myocardial Infarction 3.8%
Drug Ineffective 3.6%
Pneumonia 3.3%
Renal Failure Acute 3.2%
Pain 3.1%
Renal Failure 3.0%
Tremor 3.0%
Death 3.0%
Off Label Use 2.8%
Hyperglycaemia 2.5%
Vision Blurred 2.5%
Urinary Tract Infection 2.4%
Thrombocytopenia 2.3%
Pain In Extremity 2.1%
Interacting
Product Used For Unknown Indication 37.8%
Diabetes Mellitus 17.8%
Hypertension 8.9%
Blood Cholesterol Increased 5.6%
Sinusitis 4.4%
Pruritus Genital 3.3%
Smoking Cessation Therapy 3.3%
Cardiac Disorder 2.2%
Glaucoma 2.2%
Pain 2.2%
Type 1 Diabetes Mellitus 2.2%
Acute Sinusitis 1.1%
Atrial Fibrillation 1.1%
Benign Prostatic Hyperplasia 1.1%
Depression 1.1%
Hypothyroidism 1.1%
Localised Infection 1.1%
Onychomycosis 1.1%
Osteomyelitis 1.1%
Tinea Infection 1.1%
Hypoglycaemia 33.3%
Tremor 16.7%
Blood Glucose Decreased 11.1%
Therapy Change 11.1%
Weight Increased 11.1%
Hunger 5.6%
Muscle Spasticity 5.6%
Rhabdomyolysis 5.6%